Primary contact

Nanome is a software company that is changing the way humanity understands and interacts with science. It enables global real-time collaboration using VR from general chemistry to pharmaceutical drug discovery, all while accelerating innovation and understanding in an intuitive manner. By doing so, Nanome empowers people to take on the challenge of designing at the nano-scale. The company collaborates with a number of firms, including Nimbus Therapeutics, Fujitsu, Insilico Medicine, and SynbioBeta.
Primary contact

Funding 💰

Total $6.4M
Select investors Bullpen Capital, Sparkland Capital, Keshif Ventures, Formic Ventures, HTC Vive X Accelerator
Last update: February 10, 2021